MARTIN JOSEPH DECKER

Allopathic & Osteopathic Physicians|Family Medicine MEADVILLE, PA NPI 1831152099

General Payments — all program years on this page

$8,738.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 460
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $687.43 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $687.4320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $810.8047
2019 $833.7650
2020 $1,184.4865
2021 $2,224.55133
2022 $1,889.6693
2023 $1,108.3152
2024 $687.4320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078153403 Janssen Pharmaceuticals, Inc $16.65 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096627706 Novo Nordisk Inc $19.07 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096829981 Novo Nordisk Inc $16.54 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097358299 Novo Nordisk Inc $14.65 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097524447 Novo Nordisk Inc $14.30 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097646458 Novo Nordisk Inc $18.49 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114631001 Exact Sciences Corporation $23.31 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114631007 Exact Sciences Corporation $108.82 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116688604 GlaxoSmithKline, LLC. $16.76 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125293138 Abbott Laboratories $107.84 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125293140 Abbott Laboratories $81.58 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131416109 PFIZER INC. $14.78 11/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132011666 PFIZER INC. $15.72 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132034217 PFIZER INC. $16.10 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135176963 Lilly USA, LLC $22.67 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135199200 Lilly USA, LLC $18.85 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139309464 Astellas Pharma US Inc $32.94 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147288464 Mylan Specialty L.P. $96.11 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150124215 SHIELD THERAPEUTICS INC $16.97 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151054585 Phathom Pharmaceuticals, Inc. $15.28 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.